Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drugs for Alzheimer's disease: are they effective?

Literature DB >> 20498822

Drugs for Alzheimer's disease: are they effective?

David A Casey, Demetra Antimisiaris, James O'Brien.

Abstract

Entities: Disease

Year: 2010 PMID： 20498822 PMCID： PMC2873716

Source DB: PubMed Journal: P T ISSN： 1052-1372

× No keyword cloud information.

20 in total

1. Alzheimer disease: progress or profit?

Authors: Claire Mount; Christian Downton
Journal: Nat Med Date: 2006-07 Impact factor: 53.440

Review 2. Donepezil for dementia due to Alzheimer's disease.

Authors: J Birks; R J Harvey
Journal: Cochrane Database Syst Rev Date: 2006-01-25

3. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.

Authors: Amir Qaseem; Vincenza Snow; J Thomas Cross; Mary Ann Forciea; Robert Hopkins; Paul Shekelle; Alan Adelman; David Mehr; Kenneth Schellhase; Doug Campos-Outcalt; Pasqualina Santaguida; Douglas K Owens
Journal: Ann Intern Med Date: 2008-03-04 Impact factor: 25.391

4. Does analysis using "last observation carried forward" introduce bias in dementia research?

Authors: Frank J Molnar; Brian Hutton; Dean Fergusson
Journal: CMAJ Date: 2008-10-07 Impact factor: 8.262

5. The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

Authors: D S Knopman; M J Knapp; S I Gracon; C S Davis
Journal: Neurology Date: 1994-12 Impact factor: 9.910

Review 6. The safety and tolerability of donepezil in patients with Alzheimer's disease.

Authors: Stephen Jackson; Richard J Ham; David Wilkinson
Journal: Br J Clin Pharmacol Date: 2004-11 Impact factor: 4.335

7. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.

Authors: Pierre N Tariot; Martin R Farlow; George T Grossberg; Stephen M Graham; Scott McDonald; Ivan Gergel
Journal: JAMA Date: 2004-01-21 Impact factor: 56.272

8. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.

Authors: J L Cummings; M Mega; K Gray; S Rosenberg-Thompson; D A Carusi; J Gornbein
Journal: Neurology Date: 1994-12 Impact factor: 9.910

9. Donepezil for the treatment of agitation in Alzheimer's disease.

Authors: Robert J Howard; Edmund Juszczak; Clive G Ballard; Peter Bentham; Richard G Brown; Roger Bullock; Alistair S Burns; Clive Holmes; Robin Jacoby; Tony Johnson; Martin Knapp; James Lindesay; John T O'Brien; Gordon Wilcock; Cornelius Katona; Roy W Jones; Julia DeCesare; Michaela Rodger
Journal: N Engl J Med Date: 2007-10-04 Impact factor: 91.245

Review 10. Cholinesterase inhibitors for Alzheimer's disease.

Authors: J Birks
Journal: Cochrane Database Syst Rev Date: 2006-01-25

62 in total

1. Examining the Relationship Between Religious and Spiritual Motivation and Worry About Alzheimer's Disease in Later Life.

Authors: Jennifer R Roberts; Molly Maxfield
Journal: J Relig Health Date: 2018-12

2. Crocus sativus Extract Tightens the Blood-Brain Barrier, Reduces Amyloid β Load and Related Toxicity in 5XFAD Mice.

Authors: Yazan S Batarseh; Sonali S Bharate; Vikas Kumar; Ajay Kumar; Ram A Vishwakarma; Sandip B Bharate; Amal Kaddoumi
Journal: ACS Chem Neurosci Date: 2017-05-15 Impact factor: 4.418

Review 3. 'Evolutionary medicine' perspectives on Alzheimer's Disease: Review and new directions.

Authors: Molly Fox
Journal: Ageing Res Rev Date: 2018-07-27 Impact factor: 10.895

4. Do antidepressant medications work?

Authors: David A Casey
Journal: P T Date: 2013-03

5. Trends in Drug Prescription Rates for Dementia: An Observational Population-Based Study in France, 2006-2014.

Authors: Mathilde François; Jonathan Sicsic; Alexis Elbaz; Nathalie Pelletier Fleury
Journal: Drugs Aging Date: 2017-09 Impact factor: 3.923

Review 6. Enhancing Cognitive Functioning in Healthly Older Adults: a Systematic Review of the Clinical Significance of Commercially Available Computerized Cognitive Training in Preventing Cognitive Decline.

Authors: Tejal M Shah; Michael Weinborn; Giuseppe Verdile; Hamid R Sohrabi; Ralph N Martins
Journal: Neuropsychol Rev Date: 2017-01-14 Impact factor: 7.444

10. Physiological Aβ Concentrations Produce a More Biomimetic Representation of the Alzheimer's Disease Phenotype in iPSC Derived Human Neurons.

Authors: Bonnie J Berry; Alec S T Smith; Christopher J Long; Candace C Martin; James J Hickman
Journal: ACS Chem Neurosci Date: 2018-05-22 Impact factor: 4.418